CAS number: 102625-70-7
Chemical Formula: C16H15F2N3O4S
Treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis
Pantoprazole for injection is indicated for short-term treatment (7-10 days) of patients having gastroesophageal reflux disease (GERD) with a history of erosive esophagitis, as an alternative to oral medication in patients who are unable to continue taking pantoprazole delayed-release tablets. Safety and efficacy of pantoprazole injection as the initial treatment of patients having GERD with a history of erosive esophagitis have not been demonstrated at this time [Label].
Pathological Hypersecretion Associated with Zollinger-Ellison Syndrome
Pantoprazole for injection is indicated for the treatment of pathological hypersecretory conditions associated with Zollinger-Ellison Syndrome or other neoplastic conditions.